(S1 (S (NP (NP (NP (NP (NN GDP)) (CC and) (NP (NN AGE))) (NNS receptors)) (: :) (NP (NP (NNS mechanisms)) (PP (IN of) (NP (JJ peritoneal) (NN damage)))) (. .))))
(S1 (S (S (NP (NP (JJ Long-term) (NN peritoneal) (NN dialysis)) (PRN (-LRB- -LRB-) (NP (NN PD)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN limited) (PP (IN by) (NP (NP (JJ morphological) (NNS changes)) (PP (IN of) (NP (DT the) (JJ peritoneal) (NN membrane)))))))) (. .)))
(S1 (S (S (NP (JJ Structural) (NNS changes)) (VP (VBD were) (VP (VBN promoted) (PP (IN by) (NP (NP (NN toxicity)) (PP (IN of) (NP (NP (NP (NN glucose) (NN degradation) (NNS products)) (PRN (-LRB- -LRB-) (NP (NNS GDPs)) (-RRB- -RRB-))) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN generated) (PP (IN during) (NP (NP (NN heat) (NN sterilization)) (PP (IN in) (NP (NP (JJ peritoneal) (NN dialysis) (NNS fluids)) (PRN (-LRB- -LRB-) (NP (NNS PDFs)) (-RRB- -RRB-))))))))))))))))) (. .)))
(S1 (S (S (PP (IN Besides) (NP (PRP$ their) (JJ direct) (NN toxicity) (NN GDPs))) (VP (VBP promote) (NP (NP (NN formation)) (PP (IN of) (NP (NP (JJ advanced) (NN glycation) (NNS endproducts)) (PRN (-LRB- -LRB-) (NP (NNS AGEs)) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (NP (NP (NN RAGE)) (PRN (-LRB- -LRB-) (NP (NP (NN receptor)) (PP (IN for) (NP (NN AGE)))) (-RRB- -RRB-))) (VP (VP (VBZ is) (NP (NP (DT the) (ADJP (RB best) (VBN characterized)) (NN signal) (NN transduction) (NN receptor)) (PP (IN for) (NP (NNS AGEs))))) (CC and) (VP (VBZ is) (VP (VBN expressed) (PP (IN on) (NP (JJ mesothelial) (NNS cells))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NNS PDFs)) (PP (IN with) (NP (NP (JJ different) (NNS amounts)) (PP (IN of) (NP (NN GDPs)))))))) (VP (VBD were) (VP (VBN compared) (PP (IN on) (NP (NP (JJ morphological) (NNS changes)) (PP (IN in) (NP (NP (DT the) (JJ peritoneal) (NN membrane)) (PP (IN in) (NP (DT a) (NN RAGE) (NN -/-) (NN mouse) (NN model)))))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (MD could) (VP (VB be) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN RAGE)) (VP (VBZ plays) (NP (DT a) (JJ pivotal) (NN role)) (PP (IN in) (NP (NP (NP (JJ structural) (NN damage)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (NP (NP (NN inflammation)) (, ,) (NP (NN neoangiogenesis)) (CC and) (NP (NN fibrosis)))) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (JJ peritoneal) (NN membrane)))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Further) (NNS investigations)) (PP (IN of) (NP (DT this) (NN pathway))) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (S (VP (VBG preventing) (NP (JJ peritoneal) (NN fibrosis)))))))) (VP (MD should) (VP (VB be) (VP (VBN performed) (S (VP (TO to) (VP (VB maintain) (NP (NP (DT the) (NN integrity)) (PP (IN of) (NP (NP (DT the) (JJ peritoneal) (NN membrane)) (PP (IN in) (NP (JJ peritoneal) (NN dialysis) (NNS patients))))))))))))) (. .)))
